From November, patients with two types of cancers will be eligible to receive CAR T-cell treatment under Taiwan's National Health Insurance (NHI) system, the National Health Insurance Administration (NHIA) said Sunday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Taiwan shares end up on U.S.-China talks progress
05/12/2025 05:30 PM - Politics
Scholar urges Taiwan to enhance ties with democracies other than U.S.
05/12/2025 05:04 PM - Business
U.S. dollar closes higher on Taipei forex market
05/12/2025 04:18 PM - Politics
'De-Han-ification'? Executive Yuan webpage edit sparks controversy
05/12/2025 04:07 PM - Business
TSMC ranked as No. 10 most valuable company globally in 2025
05/12/2025 03:38 PM